The Ongoing Fight Against Diabetes
On World Diabetes Day, CTA’s Harry Parsons delves in to the disease, looking...
-
![Diabetes 2]()
How to Conduct a Diabetes Trial – Lessons Learned
-
![shutterstock_1068382157]()
Surveying the Challenges of Preclinical Development
-
![shutterstock_174171716]()
Industry Viewpoints: The Continual Rise of Direct-to-Patient
-
![6154114]()
The Date Is 10/10 – But Is Your Mental Health?
-
![shutterstock_660852628]()
Expert Insights: Will the UK Relax Its Current Regulations for Cannabis-Based Product
-
![shutterstock_335366177_2]()
Patient Recruitment Strategies for Rare Diseases – Part II: Obtaining Access to a Limited Patient Pool
Most Read
Latest Content
The Ongoing Fight Against Diabetes
On World Diabetes Day, CTA’s Harry Parsons delves in to the disease, looking at the impact it has on families and the ongoing search to find a cure
How to Conduct a Diabetes Trial – Lessons Learned
Jacqueline Mardell, Vice President of Clinical Operations, Ascendis Pharma, recounts experiences from a multinational type 2 diabetes trial and draws conclusions
Surveying the Challenges of Preclinical Development
CTA’s Adeola Coker delves into the key issues facing preclinical trials ahead of Arena International’s upcoming Preclinical Development Operations Summit in November
Industry Viewpoints: The Continual Rise of Direct-to-Patient
Michael Sparozic, Lead Trial Supply Operations Manager, Sanofi, address the merits of direct-to-patient shipping to CTA’s Jisong Seo
The Date Is 10/10 – But Is Your Mental Health?
On Mental Health Day, CTA’s Harry Parsons draws attention to mental health awareness
Expert Insights: Will the UK Relax Its Current Regulations for Cannabis-Based Product
Patrick Aiyes, MEng, Immunology Analyst, GlobalData, examines whether the UK is changing its perception on the role of cannabis-based treatments in clinical trials
Patient Recruitment Strategies for Rare Diseases – Part II: Obtaining Access to a Limited Patient Pool
Ramani A. Aiyer, Principal, Shasta BioVentures, offers a primer on patient recruitment strategies for rare disease clinical trials
Clear Clinical Trial Information is the Key to Patient Engagement
Deborah Collyar, Patient Advocates in Research (PAIR) and Catina O’Leary, Health Literacy Media, show why public study summaries need more than plain language to be effective
The 7 Deadly Sins of Audits and Inspections
Stuart Halasz, Associate Director, Clinical Quality Management, Merck & Co., Inc., focuses on “7 Deadly Sins” in Audits and Inspections – and thoughts on reducing their occurrence
EU Clinical Trial Regulation: The Long Path to Implementation
Surendra Gokhale & Claire Berry, Roche, discuss the journey, challenges and opportunities of the Clinical Trial Regulation
Latest News
Read our magazine
Global Defence Technology is the essential reading material for decision-makers in the defence industry, bringing you the latest news and analysis in an exciting, interactive format.
